Newsroom

In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in some of the news content posted here.

Stanford Launches Study of COVID-19 Vaccine Effects

New Zealand Scientists Publish Study of Antibodies That Neutralize COVID-19

UK Service Keeps High-Risk Patients Out of Hospital

NIH Develops Robust SARS-CoV-2 Serology ELISAs from Serum and Dried Blood Microsamples

Telehealth, Telemedicine’s Rapid Rise Requires Remote Specimen Collection

Analyticon 2020 Webinar Spotlights Remote Blood Collection for Virtual Studies

Toxicologists Use Microsampling to Quantify Alcohol Abuse Biomarker

LGC COVID-19 Antibody Assay Processes up to 40,000 Tests Per Day in UK

HUPO Webinar Highlights Remote Microsampling in Proteomics, Precision Medicine

Wellness Company 'for you eHealth' Offers Immunity Home Testing Kits

Neoteryx Launches Online Directory of Labs that Offer Anaylsis for Mitra Microsamples

Neoteryx Updates Its Remote Blood Collection Kits to Support Customers

Neoteryx Provides Remote Blood Collection Kits for COVID-19 Research

COVID-19 Catalyzes Remote Blood Collection With Mitra From Neoteryx

COVID-19 Screening Before Re-Entry to Work, School, Military

Neoteryx's Mitra Blood Collection Device Registered With TGA in Australia

Physicians Lab Launches Home Health & Wellness Kits With Mitra Devices from Neoteryx

Neoteryx Blood Collection Devices Support UC San Diego COVID-19 Studies

COVID-19 Tests? Consider a Finger-Prick Instead of a Regular Blood Draw

University of Rochester Examines Blood to Detect COVID-19 Antibodies

NIH Begins Study to Quantify Undetected Cases of Coronavirus Infection

GX Sciences™ now offers Microsampling, an easier and more efficient method of traditional blood sampling

Ghent University Scientists Use VAMS™ to Measure a Novel Biomarker for Alcohol Abuse

Neoteryx Expands European Footprint with Opening of Neoteryx B.V.

UK Initiative Offers At-home Microsampling Devices to Children

Neoteryx LLC and Cedars-Sinai Partner to Investigate At-Home Blood Sampling Possibilities for Patients with Inflammatory Bowel Disease

New Study Validates Neoteryx's VAMS™ Technology for At-home Blood Collection In Monitoring HbA1c Levels of Diabetic Children

Alcala Labs First to Integrate Neoteryx's VAMS Technology for Substance Abuse Monitoring

Duke University Uses Mitra Devices to Field-Test Diagnostic Tools in Liberia

microsampling goes mainstream

Quest Diagnostics Adds At-Home Collection to Expand Blueprint for Athletes™ Service Using Mitra Microsampling Technology

introducing the HemaTIP™, a microsampling product from Charles River Laboratories

Neoteryx announces an automation solution for Mitra Microsampling technology

Exagen Diagnostics' microsampling method gains wider acceptance

neoteryx adds 20 µL sample collection devices to Mitra microsampling portfolio

mitra microsampler now registered at FDA as a medical device

neoteryx mitra microsampling device wins R&D 100 award

neoteryx and Brechbühler partner to automate the mitra microsampling workflow

neoteryx announces european approval of the mitra microsampling device

neoteryx mitra (RUO) microsampling device simplifies collection, transport, and storage of biological fluids

phenomenex announces spin-off of a microsampling technology company – neoteryx llc

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs
Neoteryx Experts

Media Contacts
Media Assets
Scientific Research Publications

social media

subscribe to news

Fuel Your Innovative Approach to Science & Research. Subscribe to Our Microsampling Newsletter!

Get Our Newsletter

 

Get in Touch

 

Neoteryx, LLC

© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501

This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.

Get To Know Us

Follow Us

Mitra® is an exempt medical device in the US, CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, and registered with Health Canada. It is intended as a specimen collector and for the storage and transport of biological fluids. Use of the device with blood for diagnostic applications is limited to certain countries and, in the US, for research and non-diagnostic purposes only. Neoteryx Products are not marketed in the US for clinical diagnostic uses. In other countries, Neoteryx Products may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.

Copyright © 2020 Neoteryx, LLC. All rights reserved.